Tag: GLENNON SMALL COMPANIES LTD
-
Glennon Small Companies Ltd Reports Strong Performance with Strategic Investments
Glennon Small Companies Ltd has outperformed its benchmark in January 2025 with a 4.66% return, largely due to successful investments in Telix Pharmaceuticals and Pro Medicus. Despite challenges from Zip Co, the portfolio’s 12-month return is 27.35%, notably higher than the benchmark’s 12.32%. The firm, focused on small-cap investments, has a year-to-date performance of -2.08%…
-
Glennon Small Companies Ltd Announces January NTA Figures
• Glennon Small Companies Ltd announced January 2025 unaudited NTA figures. • Before-tax NTA at $0.8136 per share; after-tax at $0.7770. • Year-to-date price performance at -1.04%, with an average trading volume of 28,549. • Technical sentiment consensus rating: Sell. Investment Overview Glennon Small Companies Limited recently revealed its unaudited Net Tangible Assets (NTA) as…